BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution formIt is a more patient-friendly way to tackle prostate cancer. It can help improve patient compliance to a great extent, Badiger said. The co...
02 Jan, 2024, 02.09 PM IST
BDR Pharma CMD’s family buys luxury apartments in Mumbai’s Worli for Rs 81 crThe performance in terms of stamp duty collection led by the heightened activity in premium and mid-income housing segments have also pushe...
27 Nov, 2023, 06.09 PM IST
BDR Pharmaceutical launches generic drug for treating prostate cancer in IndiaBDR Group Director Business Development Raheel Shah said that the launch of APATIDE is "testimony towards our commitment in providing acces...
03 Jan, 2023, 03.33 PM IST
Generic drug companies in no hurry to launch new Covid productsBDR Pharmaceuticals, a Mumbai-based active pharmaceutical ingredient (API) manufacturing company, has developed the API of antiviral pill P...
13 Jul, 2022, 12.34 AM IST
Mankind, BDR Pharma join hands to launch anti COVID-19 pill MolulifeMankind Pharma on Wednesday said it has joined hands with BDR Pharmaceuticals to launch oral anti-COVID-19 pill Molulife (Molnupiravir) in ...
29 Dec, 2021, 03.02 PM IST
USFDA approves COVID antiviral pill molnupiravir for emergency useThe USFDA also said the drug should be given for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or cl...
23 Dec, 2021, 08.53 PM IST
BDR Pharma inks licensing pact with Eli Lilly for COVID-19 treatment drugBaricitinib has received restricted emergency use approval, for use in combination with Remdesivir, for treatment of suspected or laborator...
19 May, 2021, 02.20 PM IST
Indian drug companies start off a price war on experimental Covid-19 drugOver the next few weeks, close to 10 drug companies including Abbott, Lupin, Micro Labs, Mcleods Pharma, Cipla, Strides Pharma and Dr Reddy...
25 Jul, 2020, 07.49 AM IST
Hetero, Cipla to supply generic Remdesivir to hospitals this weekThe recommended course for a Covid-19 patient under oxygen support is five vials. The approved therapy is for moderate to severe patients.
22 Jun, 2020, 04.15 PM IST
Delhi HC Upholds BMS' Patent for Cancer Drug DasatinibThe Delhi High Court has upheld the patent of US-based BMS for Dasatinib, dashing the hopes of a local company to sell a generic version of...
07 Jul, 2015, 10.50 AM IST
Delhi High Court upholds BMS’ patent for cancer drug DasatinibThe Indian Patent Office had in 2013 rejected the company’s demand for a compulsory licence as it did not follow the procedures for obtaini...
06 Jul, 2015, 05.37 AM IST
Dose of bitter pills, few booster injections for pharma sectorThe pharma sector, estimated to be around Rs 1.5 lakh cr, recorded single digit growth for the first time in many years on account of deepe...
29 Dec, 2013, 12.31 PM IST
Government rejects BDR Pharma's CL application for anti-cancer drugUnder the Indian Patents Act, if a medicine is deemed unaffordable, a compulsory licence can be issued to a generic drug maker in public in...
10 Nov, 2013, 12.09 PM IST
Patent office rejects BDR Pharma’s compulsory licensing applicationThe Patent Office rejected BDR’s application on the grounds that the company did not make enough efforts to obtain a voluntary licence for ...
31 Oct, 2013, 05.49 AM IST
- Roselabs in talks with pharma majors to supply pre-filled syringes
Roselabs Bioscience said it is in talks with some of the large Hyderabad-based pharma, biotech firms including Dr Reddy’s Labs and Bharat B...
18 Jul, 2013, 06.55 PM IST